In this issue:
Gene therapy for transfusiondependent β-thalassaemia
Metabolic syndrome in adult survivors of childhood acute leukaemia
Tocilizumab added to tacrolimus and methotrexate for preventing acute GVHD
Major bleeding episodes associated with oral anticoagulant use
Venetoclax for CLL that progresses on idelalisib
CD83: a potential biomarker/ therapeutic target for HL?
Adding ibrutinib to standard therapy in relapsed/refractory DLBCL
How novel therapies have changed MCL management in the real world
Investigation and management of raised serum ferritin levels
Please login below to download this issue (PDF)